CHOP versus CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma - Reply

被引：0
|
作者：
Doorduijn, JK [1 ]
Sonneveld, P [1 ]
机构：
[1] Erasmus MC, Dept Hematol, Rotterdam, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 21期
关键词：
D O I：
10.1200/JCO.2005.014464
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4799 / 4800
页数：2
相关论文
共 50 条
  • [1] CHOP versus CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma
    Alliot, C
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (21) : 4797 - 4799
  • [2] CHOP compared with CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma
    Doorduijn, JK
    van der Holt, B
    van Imhoff, GW
    van der Hem, KG
    Kramer, MHH
    van Oers, MHJ
    Ossenkoppele, GJ
    Schaafsma, MR
    Verdonck, LF
    Verhoef, GEG
    Steijaert, MMC
    Buijt, I
    Uyl-de Groot, CA
    van Agthoven, M
    Mulder, AH
    Sonneveld, P
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (16) : 3041 - 3050
  • [3] Full-dose CHOP chemotherapy combined with granulocyte colony-stimulating factor for aggressive non-Hodgkin's lymphoma in elderly patients: a prospective study
    N. Niitsu
    K. Iijima
    Annals of Hematology, 2001, 80 : 602 - 606
  • [4] Full-dose CHOP chemotherapy combined with granulocyte colony-stimulating factor for aggressive non-Hodgkin's lymphoma in elderly patients: a prospective study
    Niitsu, N
    Iijima, K
    ANNALS OF HEMATOLOGY, 2001, 80 (10) : 602 - 606
  • [5] Fourteen-day CHOP supported with granulocyte colony-stimulating factor in patients with aggressive non-Hodgkin's lymphoma: Results of a phase II study
    Gregory, SA
    Case, DC
    Bosserman, L
    Litwak, DL
    Berry, WR
    Kalman, LA
    Belt, RJ
    Saven, A
    CLINICAL LYMPHOMA, 2003, 4 (02): : 93 - 98
  • [6] Elderly patients with aggressive non-Hodgkin's lymphoma treated with CHOP chemotherapy plus granulocyte-macrophage colony-stimulating factor:: Identification of two age subgroups with differing hematologic toxicity
    Gómez, H
    Mas, L
    Casanova, L
    Pen, DLK
    Santillana, S
    Valdivia, S
    Otero, J
    Rodriguez, W
    Carracedo, C
    Vallejos, C
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (07) : 2352 - 2358
  • [7] Granulocyte Colony-Stimulating Factor (GCSF) Use with Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone plus /- Rituximab ( CHOP±R) Treatment for Aggressive Non-Hodgkin's Lymphoma (aNHL)
    Kouroukis, Tom
    Cheung, Winson Y.
    Abdel-Samad, Nizar
    Sehdev, Sandeep
    Poulin-Costello, Melanie
    Gillesby, Brad
    Robson, Ewan J. D.
    BLOOD, 2016, 128 (22)
  • [8] Randomized trial of granulocyte-colony stimulating factor (G-CSF) added to CHOP in elderly patients with aggressive non-Hodgkin's lymphoma (NHL).
    Doorduijn, JK
    van der Holt, B
    van der Hem, KG
    van Imhoff, GW
    Kramer, MHH
    van Oers, MHJ
    Ossenkoppele, GJ
    Schaafsma, MR
    Verdonck, LF
    Verhoef, GEG
    Steijaert, MMC
    Lowenberg, B
    Sonneveld, P
    BLOOD, 2000, 96 (11) : 133A - 133A
  • [9] Economic evaluation of prophylactic granulocyte colony-stimulating factor during chemotherapy in elderly patients with aggressive non-Hodgkin's lymphoma
    Doorduijn, JK
    Buijt, I
    van der Holt, B
    van Agthoven, M
    Sonneveld, P
    Groot, CAU
    HAEMATOLOGICA, 2004, 89 (09) : 1109 - 1117
  • [10] Cost-effectiveness analysis of rituximab plus CHOP versus CHOP in patients with aggressive non-Hodgkin lymphoma
    Berto, P
    Morsanutto, A
    Lopatriello, S
    VALUE IN HEALTH, 2004, 7 (06) : 643 - 644
12345